“阴伟达”终究不是英伟达!

药闻康策
Feb 27

点击上方 一键预约最新最热的医药健康新闻政策2026年2月24日晚,长春高新(000661)公告其子公司金赛药业自主研发的GenSci141软膏(用于治疗儿童阴茎短小症)临床试验申请获国家药监局批准。该消息因其产品作用部位与近期发布超预期财报的科技巨头“英伟达”谐音,被网友戏称为“阴伟达”,并迅速成为市场焦点。2月25日,长春高新股价涨停。部分市场观点基于“黑暗森林”式的焦虑,用不乏戏谑的市场乐观...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10